These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 24244378)

  • 1. Modulation of p53 expression using antisense oligonucleotides complementary to the 5'-terminal region of p53 mRNA in vitro and in the living cells.
    Gorska A; Swiatkowska A; Dutkiewicz M; Ciesiolka J
    PLoS One; 2013; 8(11):e78863. PubMed ID: 24244378
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Length variants of the 5' untranslated region of p53 mRNA and their impact on the efficiency of translation initiation of p53 and its N-truncated isoform ΔNp53.
    Górska A; Błaszczyk L; Dutkiewicz M; Ciesiołka J
    RNA Biol; 2013 Nov; 10(11):1726-40. PubMed ID: 24418891
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Role of Structural Elements of the 5'-Terminal Region of p53 mRNA in Translation under Stress Conditions Assayed by the Antisense Oligonucleotide Approach.
    Swiatkowska A; Zydowicz P; Gorska A; Suchacka J; Dutkiewicz M; Ciesiołka J
    PLoS One; 2015; 10(10):e0141676. PubMed ID: 26513723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Translation of human Δ133p53 mRNA and its targeting by antisense oligonucleotides complementary to the 5'-terminal region of this mRNA.
    Żydowicz-Machtel P; Dutkiewicz M; Swiatkowska A; Gurda-Woźna D; Ciesiołka J
    PLoS One; 2021; 16(9):e0256938. PubMed ID: 34492050
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Variants of the 5'-terminal region of p53 mRNA influence the ribosomal scanning and translation efficiency.
    Zydowicz-Machtel P; Swiatkowska A; Popenda Ł; Gorska A; Ciesiołka J
    Sci Rep; 2018 Jan; 8(1):1533. PubMed ID: 29367734
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antisense masking reveals contributions of mRNA-rRNA base pairing to translation of Gtx and FGF2 mRNAs.
    Panopoulos P; Mauro VP
    J Biol Chem; 2008 Nov; 283(48):33087-93. PubMed ID: 18832380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Translational Control in
    Swiatkowska A; Dutkiewicz M; Zydowicz-Machtel P; Szpotkowska J; Janecki DM; Ciesiołka J
    Int J Mol Sci; 2019 Oct; 20(21):. PubMed ID: 31671760
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inhibition of translation initiation by antisense oligonucleotides via an RNase-H independent mechanism.
    Boiziau C; Kurfurst R; Cazenave C; Roig V; Thuong NT; Toulmé JJ
    Nucleic Acids Res; 1991 Mar; 19(5):1113-9. PubMed ID: 1850511
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of the 5' terminal region of p53 mRNA in the p53 gene expression.
    Swiatkowska A; Zydowicz P; Sroka J; Ciesiołka J
    Acta Biochim Pol; 2016; 63(4):645-651. PubMed ID: 27776193
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of translation of hepatitis C virus RNA by 2-modified antisense oligonucleotides.
    Brown-Driver V; Eto T; Lesnik E; Anderson KP; Hanecak RC
    Antisense Nucleic Acid Drug Dev; 1999 Apr; 9(2):145-54. PubMed ID: 10355821
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Secondary structure and the role in translation initiation of the 5'-terminal region of p53 mRNA.
    Błaszczyk L; Ciesiołka J
    Biochemistry; 2011 Aug; 50(33):7080-92. PubMed ID: 21770379
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Apoptosis of tumoral and nontumoral lymphoid cells is induced by both mdm2 and p53 antisense oligodeoxynucleotides.
    Capoulade C; Mir LM; Carlier K; Lécluse Y; Tétaud C; Mishal Z; Wiels J
    Blood; 2001 Feb; 97(4):1043-9. PubMed ID: 11159535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Antisense inhibition of gene expression in cells by oligonucleotides incorporating locked nucleic acids: effect of mRNA target sequence and chimera design.
    Braasch DA; Liu Y; Corey DR
    Nucleic Acids Res; 2002 Dec; 30(23):5160-7. PubMed ID: 12466540
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phosphoramidate oligonucleotides as potent antisense molecules in cells and in vivo.
    Faria M; Spiller DG; Dubertret C; Nelson JS; White MR; Scherman D; Hélène C; Giovannangeli C
    Nat Biotechnol; 2001 Jan; 19(1):40-4. PubMed ID: 11135550
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Translation of stable hepadnaviral mRNA cleavage fragments induced by the action of phosphorothioate-modified antisense oligodeoxynucleotides.
    Hasselblatt P; Hockenjos B; Thoma C; Blum HE; Offensperger WB
    Nucleic Acids Res; 2005; 33(1):114-25. PubMed ID: 15640448
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of RNase H in hybrid-arrested translation by antisense oligonucleotides.
    Walder RY; Walder JA
    Proc Natl Acad Sci U S A; 1988 Jul; 85(14):5011-5. PubMed ID: 2839827
    [TBL] [Abstract][Full Text] [Related]  

  • 17. 5'-3'-UTR interactions regulate p53 mRNA translation and provide a target for modulating p53 induction after DNA damage.
    Chen J; Kastan MB
    Genes Dev; 2010 Oct; 24(19):2146-56. PubMed ID: 20837656
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pseudo-cyclic oligonucleotides: in vitro and in vivo properties.
    Jiang Z; Kandimalla ER; Zhao Q; Shen LX; DeLuca A; Normano N; Ruskowski M; Agrawal S
    Bioorg Med Chem; 1999 Dec; 7(12):2727-35. PubMed ID: 10658577
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Length and secondary structure of the 5' non-coding regions of mouse p53 mRNA transcripts - mouse as a model organism for p53 gene expression studies.
    Szpotkowska J; Swiatkowska A; Ciesiołka J
    RNA Biol; 2019 Jan; 16(1):25-41. PubMed ID: 30518296
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A novel dual lock method for down-regulation of genes, in which a target mRNA is captured at 2 independent positions by linked locked nucleic acid antisense oligonucleotides.
    Takata R; Makado G; Kitamura A; Watanabe H; Wada T
    RNA Biol; 2016; 13(3):279-89. PubMed ID: 26890856
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.